Author:
Trelles Guzmán C.R.,Linares Espinós E.,Ríos González E.,Alonso Dorrego J.M.,Aguilera Bazán A.,Jiménez Romero M.E.,Martínez-Piñeiro L.
Reference27 articles.
1. Global Cancer Observatory: Cancer tomorrow;Ferlay,2020
2. Economic burden of bladder cancer across the European Union;Leal;Eur Urol [Internet].,2016
3. The economics of bladder cancer: Costs and considerations of caring for this disease;Svatek;Eur Urol [Internet].,2014
4. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer;Riedl;J Urol.,2001
5. Zabell J, Konety BR. Management strategies for non–muscle-invasive bladder cancer (Ta, T1, and CIS). En: Partin AW, Dmochowski RR, Kavoussi LR, Peters CA, editores. Campbell-Walsh-Wein Urology [Internet]. 2021. p. 3091-3111.e8. Disponible en: https://www.clinicalkey.es/#!/content/3-s2.0-B9780323546423001373